Plausible linkage of hypoxia inducible factor-1α in uterine cervical cancer

Cancer Science

Volumn 97, Issue 9, 2006, Pages 861-867

  Fujimoto, Jiro ^a   Alam, Syed Mahfuzul ^a   Jahan, Israt ^a   Sato, Eriko ^a   Toyoki, Hiroshi ^a   Hong, Bao Li ^a   Sakaguchi, Hideki ^a   Tamaya, Teruhiko ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 8; MESSENGER RNA; THYMIDINE PHOSPHORYLASE;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LINKAGE ANALYSIS; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; SCORING SYSTEM; SURVIVAL RATE; UTERINE CERVIX CANCER;

ADULT; AGED; APOPTOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INTERLEUKIN-8; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL ANALYSIS; THYMIDINE PHOSPHORYLASE; UTERINE CERVICAL NEOPLASMS;

EID: 33746588547     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2006.00262.x     Document Type: Article

References (38)

1. Folkman J. Tumor angiogenesis. Adv Cancer Res 1985; 43: 175-203.
2. Wang GL, Semenza GL. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 1995; 270: 1230-7.
3. Huang LE, Arany Z, Livingston DM, Bunn HF. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J Biol Chem 1996; 271: 32253-9.
4. Kallio PJ, Pongratz I, Gradin K, McGuire J, Poellinger L. Activation of hypoxia-inducible factor 1α: Posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor. Proc Natl Acad Sci USA 1997; 94: 5667-72.
5. Ema M, Taya S, Yokotani N, Sogawa K, Matsuda Y, Fujii-Kuriyama Y. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1α regulates the VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci USA 1997; 94: 4273-8.
6. Maxwell PH, Dachs GU, Gleadle JM et al. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci USA 1997; 94: 8104-9.
7. Carmeliet P, Dor Y, Herbert JM et al. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998; 394: 485-90.
8. Ryan HE, Lo J, Johnson RS. HIF-1α is required for solid tumor formation and embryonic vascularization. EMBO J 1998; 17: 3005-15.
9. Fujimoto J, Sakaguchi H, Hirose R, Ichigo S, Tamaya T. Expression of vascular endothelial growth factor (VEGF) and its mRNA in uterine cervical cancers. Br J Cancer 1999; 80: 827-33.
10. Fujimoto J, Ichigo S, Hori M, Hirose R, Sakaguchi H, Tamaya T. Expression of basic fibroblast growth factor and its mRNA in advanced uterine cervical cancers. Cancer Lett 1997; 111: 21-6.
11. Fujimoto J, Ichigo S, Sakaguchi H et al. The expression of platelet-derived endothelial cell growth factor in uterine cervical cancers. Br J Cancer 1999; 79: 1249-54.
12. Fujimoto J, Sakaguchi H, Hirose R, Ichigo S, Tamaya T. Clinical implication of expression of platelet-derived endothelial cell growth factor (PD-ECGF) in metastatic lesions of uterine cervical cancers. Cancer Res 1999; 59: 3041-4.
13. Fujimoto J, Sakaguchi H, Aoki I, Tamaya T. The value of platelet-derived endothelial cell growth factor as a novel predictor of advancement of uterine cervical cancers. Cancer Res 2000; 60: 3662-5.
14. Fujimoto J, Sakaguchi H, Aoki I, Tamaya T. Clinical implications of expression of interleukin 8 related to angiogenesis in uterine cervical cancers. Cancer Res 2000; 60: 2632-5.
15. FIGO News. Int J Gynecol Obstet 1989; 28: 189-93.
16. 2 tension. Proc Natl Acad Sci USA 1995; 92: 5510-14.
17. Tian H, McKnight SL, Russell DW. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev 1997; 11: 72-82.
18. Hoffman EC, Reyes H, Chu FF et al. Cloning of a factor required for activity of the Ah (dioxin) receptor. Science 1991; 252: 954-8.
19. Bell DA, Flotte TJ. Factor VIII related antigen in adenomatoid tumors. Cancer 1982; 50: 932-8.
20. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. New Engl J Med 1991; 324: 1-8.
21. McCarty KS Jr, Miller LS, Cox EB, Konrath J, McCarty KS Sr. Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Laboratory Med 1985; 109: 716-21.
22. Maeda K, Chung Y, Ogawa Y et al. Thymidine phosphorylase/ platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma. Br J Cancer 1996; 73: 884-8.
23. Bradford MA. Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 315-23.
24. Nishida M, Hino A, Mori K et al. Preparation of anti-human thymidine phosphorylase monoclonal antibodies useful for detecting the enzyme levels in tumor tissues. Biol Pharm Bull 1996; 19: 1407-11.
25. Majno G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 1995; 146: 3-15.
26. Del Vecchio S, Zannetti A, Ciarmiello A et al. Dynamic coupling of 99mTc-MIBI efflux and apoptotic pathway activation in untreated breast cancer patients. Eur J Nucl Med 2002; 29: 809-14.
27. Birner P, Schindl M, Obermair A, Plank C, Breitenecker G, Oberhuber G. Overexpression of hypoxia-inducible factor 1α is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res 2000; 60: 4693-6.
28. Bachtiary B, Schindl M, Potter R et al. Overexpression of hypoxia-inducible factor 1α indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer. Clin Cancer Res 2003; 9: 2234-40.
29. Burri P, Djonov V, Aebersold DM et al. Significant correlation of hypoxia-inducible factor-1α with treatment outcome in cervical cancer treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 2003; 56: 494-501.
30. Ishikawa H, Sakurai H, Hasegawa M et al. Expression of hypoxic-inducible factor 1α predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2004; 60: 513-21.
31. Mayer A, Wree A, Hockel M, Leo C, Pilch H, Vaupel P. Lack of correlation between expression of HIF-1α protein and oxygenation status in identical tissue areas of squamous cell carcinomas of the uterine cervix. Cancer Res 2004; 64: 5876-81.
32. Chiarotto JA, Hill RP. A quantitative analysis of the reduction in oxygen levels required to induce up-regulation of vascular endothelial growth factor (VEGF) mRNA in cervical cancer cell lines. Br J Cancer 1999; 80: 1518-24.
33. Ziemer LS, Koch CJ, Maity A, Magarelli DP, Horan AM, Evans SM. Hypoxia and VEGF mRNA expression in human tumors. Neoplasia 2001; 3: 500-8.
34. Raleigh JA, Calkins-Adams DP, Rinker LH et al. Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker. Cancer Res 1998; 58: 3765-8.
35. West CM, Cooper RA, Loncaster JA, Wilks DP, Bromley M. Tumor vascularity: A histological measure of angiogenesis and hypoxia. Cancer Res 2001; 61: 2907-10.
36. Giatromanolaki A, Koukourakis MI, Sivridis E et al. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. Cancer Res 2001; 61: 7992-8.
37. Xu L, Fidler IJ. Acidic pH-induced elevation in interleukin 8 expression by human ovarian carcinoma cells. Cancer Res 2000; 60: 4610-16.
38. Ockaili R, Natarajan R, Salloum F, Fisher BJ, Jones D, Fowler AA 3rd, Kukreja RC. HIF-1 activation attenuates postischemic myocardial injury: role for heme oxygenase-1 in modulating microvascular chemokine generation. Am J Physiol Heart Circ Physiol 2005; 289: 542-8.